HASTINGS DAVID C (Chief Financial Officer) sold 12.2% of their position (22.18K shares) of ARBUTUS BIOPHARMA CORP on the open market
Open‑market sale worth $72.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0001447028-25-000040
Officer· Chief Financial Officer
Since Mar 2019
-22.18K
Net shares
Net seller
$72.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22.18K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−22.18K
Price / share
$3.28
Trade value
$72.83K
% of position
12.2%
2/4/2025
181.91K→159.72K
Total
Net shares
−22.18K
Net value
-$72.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/4/2025 | S · Sale | −22.18K | $3.28 | $72.83K | 12.2% | 181.91K | 159.72K |
| Total | −22.18K | -$72.83K | ||||||
Derivative Transactions0
No derivative transactions reported